https://www.clinicaltrialsarena.com/contractors/data/brainomix-e-lung-shows-progression-treatment-response-phase-iii-trial/pressreleases/immunoprecises-strategic-acquisition-increases-synergies-scale-efficiency/
ImmunoPrecise's Strategic Acquisition Increases Synergies, Scale and Efficiency - Clinical Trials...
Jul 29, 2019 - ImmunoPrecise is pleased to announce that it has acquired all of the issued and outstanding shares of ModiQuest Research BV.…
scale and efficiencyclinical trialsstrategicacquisitionincreases